3-aminobenzamide has been researched along with Diabetes Mellitus in 1 studies
Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Singla, S | 1 |
| Kumar, V | 1 |
| Jena, G | 1 |
1 other study available for 3-aminobenzamide and Diabetes Mellitus
| Article | Year |
|---|---|
3-aminobenzamide protects against colitis associated diabetes mellitus in male BALB/c mice: Role of PARP-1, NLRP3, SIRT-1, AMPK.
Topics: AMP-Activated Protein Kinases; Animals; Colitis; Colitis, Ulcerative; Colon; Diabetes Mellitus; Dise | 2023 |